Publications récentes
-
10 novembre 2025 CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.
Lehnertz B, Langouët M, Corneau S, MacRae T, Joe M, Schmidt EN, Spinella JF, Mayotte N, Moore S, Tellechea MF, Boivin I, Papineau L, Rojas-Sutterlin S, Tual M, Cortes CJ, Chagraoui J, Tomellini E, Desse V, Gagnon E, Macauley MS, Sauvageau G
Mol Ther 2025-11-10 ; -
27 octobre 2025 Moesin controls cell-cell fusion and osteoclast function.
Dufrançais O, Plozza M, Juzans M, Métais A, Monard SC, Bordignon PJ, Verdys P, Sanchez T, Bergert M, Halper J, Panebianco CJ, Mascarau R, Gence R, Arnaud G, Ben Neji M, Maridonneau-Parini I, Le Cabec V, Boerckel JD, Pavlos NJ, Diz-Muñoz A, Lagarrigue F, Blin-Wakkach C, Carréno S, Poincloux R, Burkhardt JK, Raynaud-Messina B, Vérollet C
J Cell Biol 2025-10-27 ;224( 11 ): -
23 octobre 2025 High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.
Richard-Carpentier G, Béliveau F, Lacoste S, Khakipoor B, Lisi V, Vladovsky M, Marquis M, Spinella JF, Gendron P, Lemieux S, Lavallée VP, Sauvageau G, Hébert J
Biomark Res 2025-10-23 ;13( 1 ):133 -
22 octobre 2025 -
25 septembre 2025 MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor.
Sohail I, Laurin SA, Kleinau G, Chunilal V, Morton A, Brenlla A, Kagiali ZCU, Blouin MJ, Tello JA, Beck-Sickinger AG, Lohse MJ, Scheerer P, Bouvier M, McCormick P, Annibale P, Biebermann H
Nat Commun 2025-09-25 ;16( 1 ):8324